Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Corcept Therapeutics (CORT) EBT: 2009-2024

Historic EBT for Corcept Therapeutics (CORT) over the last 12 years, with Dec 2024 value amounting to $161.5 million.

  • Corcept Therapeutics' EBT fell 71.21% to $15.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $88.5 million, marking a year-over-year decrease of 46.79%. This contributed to the annual value of $161.5 million for FY2024, which is 29.65% up from last year.
  • According to the latest figures from FY2024, Corcept Therapeutics' EBT is $161.5 million, which was up 29.65% from $124.6 million recorded in FY2023.
  • In the past 5 years, Corcept Therapeutics' EBT registered a high of $161.5 million during FY2024, and its lowest value of $116.2 million during FY2022.
  • In the last 3 years, Corcept Therapeutics' EBT had a median value of $124.6 million in 2023 and averaged $134.1 million.
  • In the last 5 years, Corcept Therapeutics' EBT fell by 7.05% in 2022 and then grew by 29.65% in 2024.
  • Yearly analysis of 5 years shows Corcept Therapeutics' EBT stood at $131.6 million in 2020, then dropped by 5.01% to $125.0 million in 2021, then decreased by 7.05% to $116.2 million in 2022, then increased by 7.20% to $124.6 million in 2023, then rose by 29.65% to $161.5 million in 2024.